Inactive Instrument
Quotes DiaMedica Inc. Toronto S.E.
Stocks
DMA
CA25253T1075
Biotechnology & Medical Research
|
End-of-day quote
Toronto S.E.
|
||
| - CAD | - |
|
| 11/08 | DiaMedica Therapeutics Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 11/08 | DiaMedica Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Basic data
Market Cap (CAD)
49,08,73,055
Market Cap (USD)
35,53,70,343
Net sales (CAD)
0
Net sales (USD)
0
Free-Float
56.63 %
Free-Float capitalization (CAD)
27,79,68,073
Free-Float capitalization (USD)
20,12,36,569
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 36Cr | |
| -0.94% | -0.71% | +45.60% | +103.25% | 6.85TCr | |
| -0.74% | -5.90% | +30.92% | +74.62% | 6.29TCr | |
| +3.13% | +1.71% | -12.50% | +390.48% | 2.81TCr | |
| -2.74% | -6.31% | +26.33% | +11.24% | 2.56TCr | |
| -0.54% | -5.47% | -3.88% | -18.31% | 2.47TCr | |
| -1.73% | -4.32% | +18.82% | -18.90% | 1.98TCr | |
| -4.27% | +3.07% | +211.22% | +362.48% | 1.77TCr | |
| -1.37% | -4.51% | -5.21% | +507.43% | 1.47TCr | |
| +1.14% | -0.34% | +52.38% | +163.82% | 1.45TCr | |
| Average | -0.90% | -1.63% | +40.41% | +175.12% | 2.77TCr | |
| Weighted average by Cap. | -0.80% | -1.87% | +36.49% | +139.06% |
Historical Quotes: DiaMedica Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- DMAC Stock
- DMA Stock
- Quotes DiaMedica Inc.
Select your edition
All financial news and data tailored to specific country editions
